Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr. Lal Path Labs Ltd. (NSE: LALPATHLAB), ISIN INE600L01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LALPATHLAB last traded at ₹1922.60 (+0.76%), with a 52-week range of ₹1272.00 to ₹2035.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 53.19%, FIIs 17.36%, DIIs 21.59%, mutual funds 18.79%.
EquiSense Score (ECS): 79/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.